Bettina Hansen
0000-0001-8307-3341
Leiden University Medical Centre
404 papers found
Refreshing results…
A Prospective Open Study of the Efficacy of High‐Dose Recombinant Hepatitis B Rechallenge Vaccination in HIV‐Infected Patients
870 Patients With Early Pbc Predominantly Die From Non-Liver Related Causes
640 Fibroscan Superior to Apri in Detecting Significant Liver Fibrosis in Chronic Hepatitis B and C Patients
Patients With Low Serum Albumin Levels Due to Advanced Cirrhosis Are at High Risk of Liver Failure During Antiviral Treatment for Chronic Hepatitis C
FibroScan is superior to aspartate transaminase to platelets ratio in detecting significant liver fibrosis in chronic hepatitis B and C patients
48 Weeks of Peginterferon Alfa-2a Alone or in Combination With Ribavirin for Hbeag-Negative Chronic Hepatitis B: Addition of Ribavirin Does Not Improve Response Rates
Predicting sustained hepatitis B virus eAg loss after treatment with peginterferon alpha-2b: development and validation of a practical model
Prediction of Response to Peginterferon-Alfa in Hbeag Positive Chronic Hepatitis B: A Model Based on 721 Patients
Withdrawal flares after treatment with peginterferon alpha-2b alone or in combination with lamivudine in HBeAg-positive chronic hepatitis B
Baseline Anti-Ns4a Antibodies in Combination With on-Treatment Quantitative HCV-Rna Reliably Identifies Non Responders to Peginterferon-Ribavirin Combination Therapy After 4 Weeks of Treatment
146 Prognosis of 375 Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cirrhosis. A Follow-Up to 17 Yrs
Improved Prognosis for Patients With Primary Biliary Cirrhosis Showing Relevant Biochemical Response to Udca. Results of a Multicenter Long-Term Cohort Study Involving 375 Patients
Prediction of Response to Peginterferon-Alfa in Hbeag Positive Chronic Hepatitis B - Increased Accuracy by Including HBV Dna Decline During Treatment
Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus
Epidemiological trends of pre‐malignant gastric lesions: a long‐term nationwide study in the Netherlands
Relapse after treatment with peginterferon -2b alone or in combination with lamivudine in HBeAg positive chronic hepatitis B
?-Glutamyltransferase and rapid virological response as predictors of successful treatment with experimental or standard peginterferon-?-2b in chronic hepatitis C non-responders
Meta-analysis: Inosine triphosphate pyrophosphatase polymorphisms and thiopurine toxicity in the treatment of inflammatory bowel disease
[488] WITHDRAWAL FLARES AFTER TREATMENT WITH PEGINTERFERON ALPHA-2b ALONE OR IN COMBINATION WITH LAMIVUDINE IN HBeAg-POSITIVE CHRONIC HEPATITIS B
[520] PREDICTION OF SUSTAINED ALT NORMALIZATION BY VIRAL LOAD DURING PEG-IFN ALPHA-2b TREATMENT FOR HBeAg-POSITIVE CHRONIC HEPATITIS B
Missing publications? Search for publications with a matching author name.